Lucid News has published an article covering the landscape of companies working to create DMT Therapies. Once considered fringe medicine and the domain of maverick clinical researchers, innovators in the psychedelics field are now poised to make a significant contribution to the mental health landscape worldwide. The article covers some of the cutting-edge research being […]
Small Pharma successfully completes Phase I Clinical Trial of DMT in Combination with Supportive Psychotherapy.
LONDON, Sept. 21, 2021 /PRNewswire/ -- Small Pharma Inc. (TSXV: DMT) (the "Company" or "Small Pharma"), a neuropharmaceutical company focused on psychedelic-assisted therapies, today announced both the successful completion of the Phase I part of the combined Phase I/IIa clinical trial and the initiation of the Phase IIa part in combination with psychotherapy of its lead candidate, SPL026, for the treatment of Major Depressive Disorder ("MDD").
LONDON, July 21, 2021 /CNW/ -- Small Pharma Inc. (TSXV: DMT) (the "Company" or "Small Pharma"), a neuropharmaceutical company focused on psychedelic-assisted N,N-dimethyltryptamine ("DMT") therapies, has launched a training program to educate psychologists on the process required for the support and completion of Small Pharma's DMT-assisted therapy clinical trials
Powerful hallucinogenic drug used in shamanic rituals is being trialled in the UK as a cure for depression
The hallucinogenic drug DMT is being trialled on British depression patients It is hoped it will help bring relief to those who don’t respond to normal pills Evidence suggests that DMT in combination with talking therapy can help A powerful hallucinogenic drug that has been used in shamanic rituals is being trialled by a British […]
A powerful hallucinogenic drug known for its part in shamanic rituals is being trialled as a potential cure for depression for the first time. Participants will be given the drug DMT, followed by talking therapy. It is hoped this could offer an alternative for the significant number of people who don’t respond to conventional pills […]